A study to assess the pulmonary distribution of Budesonide, Glycopyrronium and Formoterol Fumarate

Trial Identifier:	D5980C00007
Sponsor:	AstraZeneca
NCTID::	NCT03740373
Start Date:	September 2018
Primary Completion Date:	October 2018
Condition:	Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Translation
	English Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United Kingdom	Pentrebach, United Kingdom, CF48 4DR

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.